99 Episoder

  1. Long-term outcomes of pediatric patients with optic pathway glioma

    Publisert: 4.5.2024

  2. NF1 mutation and neuronal hyperexcitability

    Publisert: 12.4.2024

  3. Postoperative cerebellar mutism

    Publisert: 5.4.2024

  4. Cell cycle checkpoints and alkylating agents

    Publisert: 22.3.2024

  5. Liquid biopsy in CNS lymphoma

    Publisert: 15.3.2024

  6. Immunotherapy for glioblastoma, lessons learned

    Publisert: 8.3.2024

  7. TERTp mutation clonality in glioma

    Publisert: 27.2.2024

  8. Liquid biopsy in H3K27M glioma

    Publisert: 9.2.2024

  9. Glioma genetic profiles and electrophysiologic hyperexcitability

    Publisert: 26.1.2024

  10. Epidemiology of glioma in Belgium

    Publisert: 12.1.2024

  11. The Biology of H3K27M Mutant Gliomas

    Publisert: 23.12.2023

  12. 3D tumor volume assessment in PCNSL

    Publisert: 1.12.2023

  13. Brain-tumor related epilepsy; a SNO consensus review

    Publisert: 17.11.2023

  14. Vorasidenib and grading of IDH mutant astrocytoma

    Publisert: 27.10.2023

  15. Insulin feedback and PI3K inhibition in GBM

    Publisert: 6.10.2023

  16. SOX10 indel mutations in schwannomas

    Publisert: 22.9.2023

  17. Dendritic cell vaccines in gliomas

    Publisert: 8.9.2023

  18. Intrathecal trastuzumab for leptomeningeal metastases

    Publisert: 11.8.2023

  19. Short term topiramate for radiation induced cytotoxic edema

    Publisert: 21.7.2023

  20. Venous thromboembolism in gliomas

    Publisert: 8.7.2023

2 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site